Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?

MLA

William Balzi, et al. Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-Stage Breast Cancer? Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4273af5a2e71a262f41daa9c62b9b08f&authtype=sso&custid=ns315887.

APA

William Balzi, Sara Bravaccini, Mattia Altini, Michela Palleschi, Ilaria Massa, Sara Ravaioli, Maria Maddalena Tumedei, Andrea Rocca, & Roberta Maltoni. (2020). Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?

Chicago

William Balzi, Sara Bravaccini, Mattia Altini, Michela Palleschi, Ilaria Massa, Sara Ravaioli, Maria Maddalena Tumedei, Andrea Rocca, and Roberta Maltoni. 2020. “Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-Stage Breast Cancer?,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4273af5a2e71a262f41daa9c62b9b08f&authtype=sso&custid=ns315887.